SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a major topic of discussion following its announcement of a strategic manufacturing partnership, expected to significantly enhance production and gross margins for its fingerprint drug screening technology. This news, combined with an extremely low public float, has ignited strong, polarized opinions within the trading community, with many anticipating a substantial short squeeze. Conversely, some warn of a potential "pump and dump" given the company's prior financial hurdles, fueling the stock's high volume and extreme volatility.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp ($ESHA) is trending with intense speculative interest, driven by comparisons to other rapidly surging low-float SPACs and shell companies. The community is buzzing about its extremely tight share structure and high insider ownership, which are seen as catalysts for significant upside potential. High volatility and frequent trading halts are characteristic of the active trading, reflecting strong belief in its capacity for substantial gains.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending strongly after securing FDA approval for NEREUS, its motion-sickness treatment, which is seen as the first new pharmacologic option in decades. The community is actively discussing the drug's significant potential in addressing GLP-1 induced nausea, fueling speculation of a major pharmaceutical buyout and leading many to view the stock as currently undervalued. With additional pipeline approvals anticipated, traders are closely watching for sustained momentum as the market fully integrates this landmark development.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending amid a significant price drop, sparking a highly polarized community debate. While many express extreme bearishness, labeling it a "scam" and predicting further declines, a resilient group views current lows as a buying opportunity, citing its ISO compliance, recent network upgrades, and potential for institutional adoption. The broader crypto market sentiment continues to heavily influence discussions around XLM's future trajectory.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending following the FDA's decline to approve a competitor's Cushing's syndrome treatment, which gives Recorlev a clearer path to capture significant market share. The community is buzzing with bullish sentiment, anticipating robust growth and discussing how this immediate catalyst, alongside the company's improving profitability, should drive a substantial re-rating of the stock.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing polarized sentiment as the year concludes, with many users highlighting significant declines and predicting further downside, potentially influenced by year-end tax-loss selling. Conversely, a vocal part of the community views these suppressed prices as a major accumulation opportunity, anticipating a substantial rally and long-term payoff in the coming years.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to a significant price drop following an FDA Complete Response Letter for its relacorilant drug for Cushing syndrome, with the agency requesting additional efficacy evidence. Community discussion is polarized, with some investors calling the sell-off an overreaction given the company's existing profitable drug Korlym and other pipeline assets. The immediate focus is on whether the company can quickly find a path forward with the FDA and if current levels present a "bargain biobuy" or a "falling knife."

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is experiencing intense community discussion as its stock continues a significant downtrend, attributed by many to ongoing post-SPAC dilution and end-of-year tax-loss selling. While some investors are accumulating shares, drawing parallels to early Robinhood, a strong bearish sentiment prevails, highlighting its SPAC origins and concerns about its Chinese affiliation.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently a battleground stock, facing intense selling pressure from year-end tax loss harvesting and a recent reiterated 'Sell' rating from a major bank. While bears point to perceived overvaluation and fading hype, bulls are actively accumulating shares, emphasizing strong subscriber growth, new service expansion, and the long-term potential for a significant rebound amid evolving telehealth and GLP-1 market dynamics.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending as the community debates its recent Ethereum staking activity, with bulls optimistic about future yields and long-term potential, while a vocal segment expresses frustration over perceived underperformance relative to ETH. Many investors are questioning management decisions, citing concerns over share dilution and executive compensation, which they believe are suppressing the stock's value amidst broader market volatility and tax-loss harvesting pressures. The ongoing discussion often compares BMNR's performance as an ETH treasury to direct cryptocurrency holdings, highlighting investor division on its investment viability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AIBT $1M market cap makes this super interesting. Flagship product Phill Robot™ (massage robot) pilot program launched in Miami’s Rule Fitness in August

They also landed a longterm partnership with KEENON Robotics (service robots) similar to $RR

Video of KEENON Robots here: https://x.com/stockpicksnyc/status/1998427496845341187

From 9/29/2025 PR: “Multi-year partnership to distribute KEENON’s advanced lineup of service robots, including the DinerBot Series (T8, T9, T10, T11), ButlerBot W3, KleenBot C30 and C40, across the rapidly expanding restaurant, hospitality, retail, healthcare, and transportation sectors where rising labor costs and rapid automation adoption are driving strong revenue potential.”

Also, yesterdays PR attached below mentioning arrival of the first shipment of service robots from KEENON Robotics in Tel Aviv

Diamond Capital

Squeezy

Tracy Handy

AIBT $1M market cap makes this super interesting. Flagship product Phill Robot™ (massage robot) pilot program launched in Miami's Rule Fitness in AugustThey also landed a longterm partnership with KEENON Robotics (service robots) similar to $RRVideo of KEENON Robots below... https://t.co/zDlQVAK2VO pic.twitter.com/GEcXM42FHq

X (Formerly Twitter)

Stock Picks NYC on X (formerly Twitter): "$AIBT $1M market cap makes this super interesting. Flagship product Phill Robot™ (massage robot) pilot program launched in Miami's Rule Fitness in AugustThey also landed a longterm partnership with KEENON Robot...

$AIBT News out today, arrival of the first shipment of service robots from KEENON Robotics in Tel Aviv https://x.com/stockpicksnyc/status/1998082289285148934?s=46

AIBT trades at a $1M market cap with a major partnership with Keenon Robotics (service robots, similar to $RR)

AIBT reps will also be alongside KEENON at CES 2026

“AIBotics intends to announce a strategic partnership this week with a publicly traded company based in Israel.”  -also mention in today’s news

Link to today’s PR: https://www.globenewswire.com/news-release/2025/12/08/3201544/0/en/AIBotics-Ushers-in-a-New-Era-as-Intelligent-Service-Robotics-Arrive-in-Tel-Aviv-Redefining-Human-Machine-Interaction.html

Aside from their Keenon Robotics partnership. AIBT also has their flagship product Phill Robot™, a massage robot, which recently launched a pilot program at Miami’s Rule Fitness in August 2025

The kicker is, this is a pure robotics play trading at a 1M market cap

AIBT News out today, arrival of the first shipment of service robots from KEENON Robotics in Tel AvivAIBT trades at a $1M market cap with a major partnership with Keenon RoboticsAIBT reps will also be alongside KEENON at CES 2026"AIBotics intends to announce a strategic... https://t.co/cDIIrs93uM pic.twitter.com/hefZoExSrS

Stock Picks NYC on X (formerly Twitter): "$AIBT News out today, arrival of the first shipment of service robots from KEENON Robotics in Tel AvivAIBT trades at a $1M market cap with a major partnership with Keenon RoboticsAIBT reps will also be alongsid...

With autonomous robotics now operating in Silicon Wadi and global momentum accelerating, including reports of a potential U.S. robotics executive order...

AIBotics Ushers in a New Era as Intelligent Service Robotics Arrive in Tel Aviv, Redefining Human-Machine Interaction

StockTwits for iOS

Aibotics Ord Shs

Richtech Robotics Inc.

$AIBT Really liking this Robotics play and their partnership with KEENON https://x.com/stockpicksnyc/status/1998807312580952421?s=46

KEENON service robots (similar to $RR) with many big name clients, see videos

Chick-fil-A http://youtu.be/ltwz1McgL8M?si=wjlCLmjX6mS96anr

Burger King http://youtu.be/2bUUkzk3qlQ?si=OjvvbOY7YjiYDTgu

$HLT Hilton http://youtu.be/B4chrhfTS-o?si=0v8-jbylHttpRCa5

$WH Wyndham http://youtu.be/Tm54l5odCkU?si=2-M0qyoIa5_AQSGV

Sheraton http://youtu.be/1ZBHMIYF0gI?si=6RDef3CQJTZyYcGx

AND MANY MORE, also in the video attached below shows some of their other big name partners and these robots in use

 $1M market cap makes this super interesting. Flagship product Phill Robot™ (massage robot) pilot program launched in Miami’s Rule Fitness in August

They also landed a longterm partnership with KEENON Robotics (service robots) similar to 



From 9/29/2025 PR: “Multi-year partnership to distribute KEENON’s advanced lineup of service robots, including the DinerBot Series (T8, T9, T10, T11), ButlerBot W3, KleenBot C30 and C40, across the rapidly expanding restaurant, hospitality, retail, healthcare, and transportation sectors where rising labor costs and rapid automation adoption are driving strong revenue potential.”

Also, yesterdays PR attached below mentioning arrival of the first shipment of service robots from KEENON Robotics in Tel Aviv